This bill seeks to prohibit discrimination against participants in the 340B drug discount program, specifically focusing on 340B-covered entities and their contract pharmacies. It introduces new definitions for "340B-covered entity" and "contract pharmacy," aligning them with federal law, and establishes that drug coverage must reimburse these entities at rates no less favorable than those provided to similarly situated entities. The legislation also prohibits discriminatory practices related to fees, audits, and participation in pharmacy networks, while emphasizing patient choice by ensuring that no entity can interfere with a patient's ability to receive drugs from a 340B-covered entity or its contract pharmacy.

Furthermore, the bill establishes enforcement mechanisms, granting the attorney general jurisdiction to address violations and requiring the board of registration in pharmacy to implement regulations. It clarifies that acts of discrimination against 340B entities or pharmacies will be considered unfair or deceptive practices under existing consumer protection laws. Overall, the legislation aims to protect the integrity of the 340B program and ensure equitable treatment for its participants, enhancing protections regarding drug reimbursement and patient choice.

Statutes affected:
Bill Text: 176B-1, 176G-1, 176I-1